InvestorsHub Logo
Followers 28
Posts 398
Boards Moderated 0
Alias Born 12/10/2015

Re: GrassyKnoll post# 111326

Saturday, 07/15/2017 9:46:49 AM

Saturday, July 15, 2017 9:46:49 AM

Post# of 462738
Thanks for that, but I am aware that the term itself is not new. What I was looking into was the first time that Anavex used it to describe the potential MOA of 2-73.

I believe the first time it was described this way by Missling was in his excellent The Wall Street Transcript interview on October 21, 2016: https://seekingalpha.com/filing/3258966

He states it again in this podcast on November 9th around the 00:02:40 mark: https://player.fm/series/health-and-well-being/dr-christopher-missling-president-and-ceo-of-anavex

Interestingly on November 6th, this article had already picked up on the usage, putting their own spin on it here: https://insiderfinancial.com/anavex-life-sciences-corp-nasdaqavxl-is-changing-the-game-in-alzheimers/118101/

And, finally, as I stated in a previous post, the first time it made it into a PR looks to be on November 22, 2016 in the 41 week, pre-CTAD PR: http://www.anavex.com/anavex-life-sciences-announces-data-on-41-week-treatment-of-anavex-2-73-for-patients-with-alzheimers-disease/



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News